DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for MIS Interbody Devices 2017 - MedCore" report to their offering.
Traditionally, these devices were implanted through open surgery. However, a growing number of these devices are being implanted using minimally invasive surgery (MIS) techniques. MIS spinal fusion is made possible by complex and innovative surgical technology, allowing implantation of posterior screw/rod and interbody devices with minimal surgical damage or harm to the patient.
Proponents of MIS report that patients experience less trauma, have shorter hospital stays, use less medication after surgery and return to work sooner than patients who undergo open surgery. Skeptics of these techniques question the quality of the operation and cite that reduced access to the spine may compromise their ability to address the pathology.
Interbody devices, which are sometimes referred to as interbody cages, vary widely, and there are multiple ways of classifying them. In terms of design, interbody devices come as cages or spacers, each varying in size and shape.
For the purpose of this report, interbody devices are segmented by surgical approach.
Key Topics Covered:
Executive Summary
1. Research Methodology
2. Disease Overview
3. Product Assessment
4. Mis Interbody Device Market
Companies Mentioned
- Aesculap
- Alphatec Spine
- Amedica
- Aurora Spine
- Bacterin
- Baxano Surgical
- DePuy Synthes
- GS Medical
- Globus Medical
- Interventional Spine
- Joimax
- K2M
- Karl Storz
- Life Spine
- Medtronic
- NuVasive
- Nutech
- Orthofix
- OsteoMed
- Paradigm Spine
- RTI Surgical
- Richard Wolf
- SI-BONE
- Spineology
- Stryker
- VG Innovations
- Xtant
- Zimmer Biomet
- Zyga Technology
For more information about this report visit http://www.researchandmarkets.com/research/vbh9gf/us_market_report
